DPT Meeting: Panel 1 – Protocol Objectives & Eligibility PANEL Discussion 1: Protocol Objectives and Eligibility Moderators: Abby Bronson, Scott Berry Panelists: Joanne Donovan, MD, PhD, Catabasis Pharmaceuticals Michael Panzara, MD, MPH, Wave Life Sciences Hank Mayer, MD, Children’s Hospital of Philadelphia Paula Clemens, MD, University of Pittsburgh Gretchen Egner, Parent/Advocate 7 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings You may also like 12:20 Catabasis 6 years ago Conferences & Meetings,In the Pipeline: Reducing Inflammation 11:23 Antisense Therapeutics 6 years ago Conferences & Meetings,In the Pipeline: Reducing Inflammation 13:19 PTC Therapeutics 6 years ago Approved Therapies,Conferences & Meetings 15:43 Sarepta Therapeutics 6 years ago Approved Therapies,Conferences & Meetings 7:48 What is a Post Market Study? 6 years ago Approved Therapies,Conferences & Meetings 35:48 DPT Meeting: Welcome & Introduction 7 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 38:43 DPT Meeting: FDA Opening Remarks 7 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 23:02 DPT Meeting: DPT Protocol in Practice 7 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings «1…242526272829»Page 26 of 29